-
Tailor-made "dual carbon" implementation opinions in many places
Time of Update: 2023-03-01
Jiangsu Province proposed that it will organize the implementation of energy conservation and carbon reduction work in key industries and data centers such as oil refining, ethylene, and synthetic ammonia, which account for a high proportion of energy consumption, and resolutely eliminate outdated production capacity, outdated processes, and outdated products, and greatly improve the overall energy efficiency level of the industry .
-
"Tailor-made" tray to improve production and efficiency
Time of Update: 2023-02-02
After the completion of the transformation, the pressure difference of the low-temperature methanol washing T-1601 scrubber tower decreased, the liquid level of each layer of the tower tray was stable, the temperature points in the tower decreased compared with before, and the process gas index was stable after purification.
-
Nearly 60% of patients are terminal! How can liver cancer research be "tailored" for Chinese patients?
Time of Update: 2023-01-05
In terms of liver cancer treatment drugs, immunotherapy represented by PD-1 monoclonal antibody is changing the diagnosis and treatment pattern of middle and advanced liver cancer, and bringing breakthroughs to prolong the survival of liver cancer patients.
-
Off-grid power supply energy storage systems will become a tailor-made field for lead-acid batteries
Time of Update: 2022-11-19
Lead-acid batteries Kunar said that if we are committed to the construction of small-scale off-grid systems in remote areas, we need small-scale environmentally friendly lead-acid battery recycling systems, so we need to transform renewable energy problems into environmental protection problems.
-
A weekly inventory of "tailor-made" therapeutic cancer vaccines and early clinical data of multiple cancer therapies is eye-catching
Time of Update: 2022-11-04
Bria-IMT: Published Phase 1 Clinical Trial DataBriaCell Therapeutics has published data from a Phase 1 clinical trial of its cell candidate, Bria-IMT, in combination with Incyte's PD-1 inhibitor, retifanlimab, for the treatment of advanced breast cancer 。 Bria-IMT is a human breast cancer cell line expressing Her2/neu and is designed to produce and secrete breast cancer antigens and granulocyte-macrophage colony-stimulating factor (GM-CSF), which promotes dendritic cell-based antigen presentation and activates the immune system.
-
Tailor-made [Cloud Interview] The exclusive appointment channel of the Visual Environment Club is now open
Time of Update: 2022-10-25
The 2022 FERC Autumn Exhibition, which will be held from November 8th to November 14th, will be held at the same time as the ECE Summit Forum, cloud interviews, PPT presentations, and new product launches, which is your favorite?
-
In-depth analysis of overseas strategy, every innovative drug needs "tailor-made" clinical trials!
Time of Update: 2022-10-13
At the project establishment stage, it is necessary to consider the competitive landscape, regulatory policies and optimal listing path of the product; Preparation in the clinical phase, from trial protocol design and proof-of-concept to local patient recruitment and supply chain assurance; In terms of capital, resources in the international capital market are limited, and the financing environment is very complex, which requires adequate coping strategies.
-
Shanxi; Yuncheng Animal Husbandry and Veterinary Development Center tailors precise poverty alleviation to poor households in the village
Time of Update: 2022-09-23
I have also been to Jiandihe Village many times to introduce and guide the peasant masses to guide and cooperate with the poverty alleviation team to transport the work of the Urban Animal Husbandry and Veterinary Development Center, change the idea of planting wheat and corn grain crops, with small income and large investment, and to build one village and one product, create fine products, build brands, and increase peasants' incomes.
-
To save his brother's life, Harvard graduates tailored gene therapy for him
Time of Update: 2022-09-09
▎ WuXi AppTec content team editorOn August 9, 2022, Cure Rare Disease (CRD), a Boston-based nonprofit organization, announced that the FDA had approved its IND application for a CRISPR gene-edited therapy called CRD-TMH-001 for the treatment of Duchenne muscular dystrophy (DMD).
-
Integration of production and education to "tailor-made" talents for Henan food enterprises
Time of Update: 2022-08-31
The Food Industry College of Henan Economic and Trade Vocational College was established recently . How was the Food Industry Academy established? What are the characteristics of the School of Food I
-
LANXESS: Tailored materials for mobile charging infrastructure for electric vehicles
Time of Update: 2022-08-23
●Technology transfer and automotive application of E&E●Focus on charging plugs, charging stations, wall battery compartments and inductive charging systems●Comprehensive engineering services during component developmentIn addition to new applications for electric vehicle powertrains, specialty chemicals company LANXESS sees great potential for its technical thermoplastics in electric vehicle charging infrastructure .
-
Tailor your diet to your genotype
Time of Update: 2022-08-10
How much can you know about optimal nutrition if you have DNA information?""Can race, hair color, eye color, ancestry help you choose the best diet?
How much can you know about optimal nutrition if you have DNA information?""Can race, hair color, eye color, ancestry help you choose the best diet?
-
Filters also pay attention to "tailor-made"?
Time of Update: 2022-05-02
According to the introduction of Xinyuan Environmental Protection, the medium-efficiency multi-media filter is mainly used for water treatment to remove turbidity, pretreatment of softened water and pure water, etc.
-
J Clin Oncol: Clinical efficacy of nivolumab-tailored therapy in patients with advanced urothelial carcinoma
Time of Update: 2022-04-22
The study's tailored nivolumab therapy demonstrated significant clinical activity, supporting the use of dual checkpoint inhibitors as first-line therapy in patients with metastatic urothelial carcinoma .
The study's tailored nivolumab therapy demonstrated significant clinical activity, supporting dual-checkpoint inhibitor therapy in first-line treatment of patients with metastatic urothelial carcinoma .
-
Tailored intragastric balloon helps you lose weight
Time of Update: 2022-01-25
This article is from the NEJM Journal Watch Review of Weight Loss with Adjustable Intragastric Balloon by Bruce Soloway, MD Most patients maintain a certain amount of weight for 6 months after device removal Decrease, but the long-term effect is unknown .
